Literature DB >> 9498348

Incidence of antibiotic resistance in fecal Escherichia coli isolated from commercial swine farms.

A G Mathew1, W G Upchurch, S E Chattin.   

Abstract

Sows and pigs from 10 commercial swine farms were sampled to determine patterns of resistance of fecal Escherichia coli to five commonly used antibiotics. Before testing, farms were categorized as high or low antibiotic use based on interviews with the respective producers. On each farm, fecal swabs were obtained from five sows at 7 d postpartum and from five pigs from each sow at 7, 35, and 63 d of age. A total of 6,296 E. coli isolates from 750 pig fecal samples and a total of 462 E. coli isolates from 50 sow fecal samples were tested against apramycin, carbadox, gentamicin, neomycin, and oxytetracycline using a standardized disk diffusion test. Percentage of resistant organisms was compared between pigs at the various stages of growth, between sows and their respective pigs, and between farms of high and low antibiotic use. Incidence of resistance was greater (P < .05) in pigs at 35 or 63 d of age compared with 7 d of age for most antibiotics, and patterns differed between high-use and low-use farms. Resistance differed (P < .05) among E. coli from pigs compared to their respective sows for apramycin and carbadox on low-use farms, whereas incidence of resistance on high-use farms differed (P < .05) between sows and pigs for apramycin and oxytetracycline. These data indicate that patterns of antibiotic resistance are dependent on age of pig and level of antibiotic use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498348     DOI: 10.2527/1998.762429x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  8 in total

1.  Antimicrobial resistance in enteric pathogens isolated from Minnesota pigs from 1995 to 2004.

Authors:  Yashpal S Malik; Yogesh Chander; Karen Olsen; Sagar M Goyal
Journal:  Can J Vet Res       Date:  2011-04       Impact factor: 1.310

2.  Plasmid-encoded Tet B tetracycline resistance in Haemophilus parasuis.

Authors:  John F Lancashire; Tamsin D Terry; P J Blackall; Michael P Jennings
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 3.  Concentrated swine feeding operations and public health: a review of occupational and community health effects.

Authors:  D Cole; L Todd; S Wing
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

4.  Development of aminoglycoside and β-lactamase resistance among intestinal microbiota of swine treated with lincomycin, chlortetracycline, and amoxicillin.

Authors:  Jian Sun; Liang Li; Baotao Liu; Jing Xia; Xiaoping Liao; Yahong Liu
Journal:  Front Microbiol       Date:  2014-11-04       Impact factor: 5.640

5.  Comparison of Fecal Microbial Composition and Antibiotic Resistance Genes from Swine, Farm Workers and the Surrounding Villagers.

Authors:  Jian Sun; Ting Huang; Chong Chen; Ting-Ting Cao; Ke Cheng; Xiao-Ping Liao; Ya-Hong Liu
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

6.  Effects of the antimicrobial peptide WK3 on diarrhea, growth performance and intestinal health of weaned piglets challenged with enterotoxigenic Escherichia coli K88.

Authors:  Licong Zhang; Tao Guo; Na Zhan; Taotao Sun; Anshan Shan
Journal:  Food Nutr Res       Date:  2021-05-11       Impact factor: 3.894

7.  Describing antimicrobial use and reported treatment efficacy in Ontario swine using the Ontario Swine Veterinary-based Surveillance program.

Authors:  Shiona K Glass-Kaastra; David L Pearl; Richard J Reid-Smith; Beverly McEwen; Scott A McEwen; Rocio Amezcua; Robert M Friendship
Journal:  BMC Vet Res       Date:  2013-12-01       Impact factor: 2.741

8.  Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries.

Authors:  Dongsheng Yang; Dick J J Heederik; Dik J Mevius; Peter Scherpenisse; Roosmarijn E C Luiken; Liese Van Gompel; Magdalena Skarżyńska; Katharina Wadepohl; Claire Chauvin; Eri Van Heijnsbergen; Inge M Wouters; Gerdit D Greve; Betty G M Jongerius-Gortemaker; Monique Tersteeg-Zijderveld; Magdalena Zając; Dariusz Wasyl; Katharina Juraschek; Jennie Fischer; Jaap A Wagenaar; Lidwien A M Smit; Heike Schmitt
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.